ClinicalTrials.gg
RecruitingNCT05233020ROHYBUpdated Feb 10, 2022

Robotic Versus Hybrid Assisted Ventral Hernia Repair

An interventional study of robotic and hybrid in Pain, Quality of Life and Recurrence, sponsored by Kuopio University Hospital. Recruiting at 1 site in Finland. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-02-10.

Sponsored by Kuopio University Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Nov 2025, 1 year ago, but the record still lists the study as recruiting.
  • Registered 3 months after the study started (first participant enrolled Sep 2021, registered Jan 2022).
  • Started Sep 2021; still recruiting 5 years 1 month later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 70 Years
Sex
All
01

Study summary

Laparoscopic ventral hernia repair (LVHR) may be associated with chronic pain, seroma formation, bulging and failure to restore abdominal wall function. These outcomes are risk factors for hernia recurrence and poor quality of life (QoL). Our study evaluates whether robotic-assisted ventral hernia repair (rVHR) diminish these complications compared to LVHR with primary closure of the defect (hybrid).

Read the detailed description

Thirty patients undergoing incisional ventral hernia operation with fascial defect size from 3 to 6 cm will be recruited. Fifteen patients undergo rVHR and fifteen undergo hybrid operation.The main outcome measure is postoperative pain, evaluated with visual analogue scale (VAS: 0-10) preoperatively, at 1-week, at 1-month and at 1-year. Hernia recurrence will be evaluated with ultrasound examination at 1-year and QoL using the generic SF-36 short form questionnaire preoperatively, at 1-month and at 1-year.

02

Conditions studied

  • Pain
  • Quality of Life
  • Recurrence

Keywords

  • Ventral hernia
  • Laparoscopy
  • Robot-assisted
  • pain
03

In context

Pain

10,054 studies on the registry are indexed under Pain; 1,649 are open to participants now.

This study's planned enrollment of 30 is below the median of 66 across 8,493 interventional studies indexed under Pain.

Browse Pain studies →

Lead sponsor

Kuopio University Hospital is the lead sponsor of 135 studies on the registry; 24 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ventral hernia size 3-6 cm

Exclusion criteria

Exclusion Criteria:

  • previous ventral hernia
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Robotic

    Fifteen patients undergo rVHR operation.

    Device: robotic

  • Experimental
    hybrid

    Fifteen patients undergo hybrid operation.

    Device: hybrid

Interventions

  • Devicerobotic

    fifteen patients undergo robotic operation

  • Devicehybrid

    fifteen patients undergo hybrid operation

06

What researchers measure

Primary outcomes

  1. Robotic-assisted ventral hernia repair vs hybrid. Change in pain

    VAS scale from 0 to 10. Zero in VAS is no pain and number ten is the highest possible pain

    Time frame: 1-year

Secondary outcomes

  1. Robotic-assisted ventral hernia repair vs hybrid. Change in the social functioning status.

    SF-36. Scale from 0 to 100. For all scales, higher scores (100) represent better function or outcome

    Time frame: 1-year

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 10, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05233020
Responsible party
Kakela Pirjo (clinical teacher, MD, PhD, Kuopio University Hospital) — Principal investigator
First posted
Feb 10, 2022
Start date
Sep 28, 2021
Primary completion
Nov 2025 (estimated)
Completion
Nov 30, 2025 (estimated)
Last update
Feb 10, 2022

Study contacts

Pirjo Käkelä, PhD
Contact
pirjo.kakela@kuh.fi
044 717 4796
Kirsi Mustonen, MD
Contact
kirsi.m.mustonen@kuh.fi
044 717 5732
Pirjo Käkelä, PhD
study director · gi -surgeon, clinical teacher
Pirjo Käkelä, PhD
principal investigator · gi-surgeon, clinical teacher

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion